Article
A resource of potential drug targets and strategic decision-making for obstructive sleep apnoea pharmacotherapy.
Respirology (Carlton, Vic.) - 1 Jul 2017
Horner Richard L, Grace Kevin P, Wellman Andrew
Abstract excerpt
There is currently no pharmacotherapy for obstructive sleep apnoea (OSA) but there is no principled a priori reason why there should not be one. This review identifies a rational decision-making strategy with the necessary logical underpinnings that any reasonable approach would be expected to navigate to develop a viable pharmacotherapy for OSA. The process first involves phenotyping an individual to quantify...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
